Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Pepa Bruce
Observed name:
P. Bruce
Institutions:
Victoria University of Wellington,
Medical Research Institute of New Zealand
Observed institutions:
University of Oxford,
Victoria University of Wellington,
Capital and Coast District Health Board,
Medical Research Institute of New Zealand,
Imperial College London,
University of Otago
show all 6
ORCID:
0000-0002-0317-0641
Observed ORCID:
0000-0002-0317-0641
OpenAlex ID:
A5059173644
Respiratory syncytial virus: paying the immunity debt with interest
2021
·
Lee Hatter
, Allie Eathorne
, et al.
·
The Lancet Child & Adolescent Health
·
236
PDF
ICS-formoterol relieverversusICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis
2020
·
Lee Hatter
, Pepa Bruce
, et al.
·
ERJ Open Research
·
67
PDF
The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review
2023
·
Richard Beasley
, Pepa Bruce
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
61
PDF
The carbon footprint of as-needed budesonide/formoterol in mild asthma: apost hocanalysis
2024
·
Lee Hatter
, Mark Holliday
, et al.
·
European Respiratory Journal
·
33
Budesonide–formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial
2025
·
Lee Hatter
, Mark Holliday
, et al.
·
The Lancet
·
26
Patterns of Asthma Medication Use in New Zealand After Publication of National Asthma Guidelines
2023
·
Lee Hatter
, Allie Eathorne
, et al.
·
The Journal of Allergy and Clinical Immunology In Practice
·
18
What variables should inform needle length choice for deltoid intramuscular injection? A systematic review
2023
·
Ciléin Kearns
, Claire Houghton
, et al.
·
BMJ Open
·
18
PDF
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
2021
·
Lee Hatter
, Pepa Bruce
, et al.
·
ERJ Open Research
·
18
PDF
Students' participation in collaborative research should be recognised
2017
·
Aditya Borakati
, Kenneth McLean
, et al.
·
International Journal of Surgery
·
18
PDF
Single dose of budesonide/formoterol turbuhaler compared to salbutamol pMDI for speed of bronchodilator onset in asthma: a randomised cross-over trial
2022
·
Nethmi Kearns
, Mathew Williams
, et al.
·
Thorax
·
16
Patterns of asthma medication use and hospital discharges in New Zealand
2024
·
Jonathan Noble
, Lee Hatter
, et al.
·
Journal of Allergy and Clinical Immunology Global
·
12
START CARE: a protocol for a randomised controlled trial of step-wise budesonide–formoterol reliever-based treatment in children
2024
·
Tasmin Barry
, Mark Holliday
, et al.
·
ERJ Open Research
·
12
PDF
COVID-19 border controls prevent a 2021 seasonal influenza epidemic in New Zealand
2021
·
T. Hills
, L. Hatter
, et al.
·
Public Health
·
11
PDF
A breath of fresh AIR: reducing the carbon footprint of asthma
2022
·
Lee Hatter
, Pepa Bruce
, et al.
·
Journal of Medical Economics
·
10
Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials
2022
·
Lee Hatter
, Claire Houghton
, et al.
·
BMJ Open Respiratory Research
·
8
PDF
Repeated dose budesonide/formoterol compared to salbutamol in adult asthma: a randomised crossover trial
2022
·
Nethmi Kearns
, Pepa Bruce
, et al.
·
European Respiratory Journal
·
8
PDF
Anti‐inflammatory reliever therapy in asthma: The evidence mounts but more is needed
2020
·
Pepa Bruce
, Lee Hatter
, et al.
·
Respirology
·
8
PDF
The Anti-Inflammatory Reliever (AIR) Algorithm Study: a protocol for a single-group study of an AIR stepwise approach to the treatment of adult asthma
2023
·
Pepa Bruce
, Lee Hatter
, et al.
·
ERJ Open Research
·
6
PDF
Budesonide–formoterol versus terbutaline reliever in adults with asthma using maintenance inhaled corticosteroids in New Zealand (INFORM ASTHMA): an open-label, parallel-group, randomised, controlled, phase 4 trial
2026
·
Jonathan H Noble
, Orlagh Bean
, et al.
·
The Lancet Respiratory Medicine
·
3
An anti-inflammatory reliever algorithm approach to asthma management in adults: an open-label, single-arm trial
2025
·
Pepa Bruce
, Claire Houghton
, et al.
·
EClinicalMedicine
·
3
Carbon footprint of as-needed budesonide-formoterol in mild asthma: a post hoc analysis
2023
·
Lee Hatter
, Pepa Bruce
, et al.
·
European Respiratory Journal
·
3
A Proposed Revision of the Stepwise Treatment Algorithm in Asthma
2021
·
Richard Beasley
, Pepa Bruce
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
3
RCT Abstract - Budesonide-formoterol versus salbutamol as reliever therapy in children with mild asthma (CARE): a 52-week, open-label, multicentre, superiority, randomised controlled trial
2025
·
Lee Hatter
, Mark Holliday
, et al.
·
European Respiratory Journal
·
1
Examining SABA over-reliance in individuals with asthma
2025
·
Holly Foot
, Ruochen Ning
, et al.
·
European Respiratory Journal
·
1
Protocol for the INFORM ASTHMA Trial: budesonide–formoterol reliever in adults with asthma on maintenance inhaled corticosteroid
2025
·
Jonathan Noble
, Orlagh Bean
, et al.
·
ERJ Open Research
·
1
Show more works
View as search
Works count:
34
Citation count:
603
H-index:
12
I10-index:
14
Year
Topic
Type